Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D.

@article{Charlson2017GeographicVO,
  title={Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D.},
  author={John A. Charlson and Emily L. McGinley and Ann Butler Nattinger and Joan M Neuner and Liliana E. Pezzin},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  year={2017},
  volume={15 12},
  pages={
          1509-1517
        }
}
Background: Drug utilization under Medicare Part D varies significantly by geographic region. This study examined the extent to which geographic variation in Part D plan characteristics contributes to the variation in choice of initial endocrine therapy agent among women with incident breast cancer. Methods: Two-stage multivariate regression analyses were applied to the 16,541 women identified from Medicare claims as having incident breast cancer in 2006-2007. The first stage determined the… CONTINUE READING
1
Twitter Mention